Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02922413Phase 2Terminated
Panhematin for Prevention of Acute Attacks of Porphyria
Acute Intermittent PorphyriaHereditary CoproporphyriaVariegate Porphyria
PrincipalinvestigatorStart date: 2015-10-30
NCT01573754Phase 2Completed
Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
PrincipalinvestigatorStart date: 2006-03-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Karl E Anderson

University of Texas

Related
2 trials

Shared therapeutic areas:

Porphyria, Acute IntermittentCoproporphyria, HereditaryPorphyria, Variegate

Worked with same sponsors:

The University of Texas Medical Branch, Galveston
Similarity Score23%

Karl E. Anderson, M.D.

University of Texas

Related
1 trials

Shared therapeutic areas:

Porphyria, Acute IntermittentPorphyria, Variegate
Similarity Score15%

Robert J. Desnick, Ph.D., M.D.

Icahn School of Medicine at Mount Sinai

Related
1 trials

Shared therapeutic areas:

Porphyria, Acute IntermittentPorphyria, Variegate
Similarity Score15%

Herbert L. Bonkovsky, M.D.

Carolinas Medical Center and HealthCare System

Related
1 trials

Shared therapeutic areas:

Porphyria, Acute IntermittentPorphyria, Variegate
Similarity Score15%

Quinn Dinh, MD

Alnylam Pharmaceuticals

Related
1 trials

Shared therapeutic areas:

Porphyria, Acute IntermittentPorphyria, Variegate
Similarity Score15%

James P. Kushner, M.D.

University of Utah

Related
1 trials

Shared therapeutic areas:

Porphyria, Acute IntermittentPorphyria, Variegate
Similarity Score15%

Joseph R. Bloomer, M.D.

University of Alabama at Birmingham

Related
1 trials

Shared therapeutic areas:

Porphyria, Acute IntermittentPorphyria, Variegate
Similarity Score15%

Bruce Wang, M.D.

University of California at San Francisco

Related
1 trials

Shared therapeutic areas:

Porphyria, Acute IntermittentPorphyria, Variegate
Similarity Score15%

Eliane Sardh, MD PhD

Studieenheten, Akademiskt Specialistcentrum, Stockholm Läns Sjukvårdsområde, Region Stockholm

Related
1 trials

Shared therapeutic areas:

Porphyria, Acute Intermittent

Worked with same sponsors:

The University of Texas Medical Branch, Galveston
Similarity Score8%

Sean Rudnick, MD

Wake Forest University Health Sciences

Related
1 trials

Shared therapeutic areas:

Porphyria Cutanea Tarda
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02922413Phase 2PrincipalInvestigator

Panhematin for Prevention of Acute Attacks of Porphyria

Acute Intermittent PorphyriaHereditary CoproporphyriaVariegate Porphyria
Terminated
NCT01573754Phase 2PrincipalInvestigator

Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda

Porphyria Cutanea Tarda
Completed

All 2 trials loaded